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mass and insulin secretion in neonatal and adult rat islets. In
the present study, we measured the short- and long-term
effects of INGAP-PP (a pentadecapeptide having the 104–
118 amino acid sequence of INGAP) upon islet protein
expression and phosphorylation of components of the PI3K,
MAPK and cholinergic pathways, and on insulin secretion.
Short-term exposure of neonatal islets to INGAP-PP (90 s, 5,
15, and 30 min) significantly increased Akt1-Ser473 and
MAPK3/1-Thr202/Tyr204 phosphorylation and INGAP-PP
also acutely increased insulin secretion from islets perifused
with 2 and 20 mM glucose. Islets cultured for 4 days in the
presence of INGAP-PP showed an increased expression of
Akt1, Frap1, and Mapk1 mRNAs as well as of the muscarinic
M3 receptor subtype, and phospholipase C (PLC)-b2
proteins. These islets also showed increased Akt1 andJournal of Endocrinology (2008) 199, 299–306
0022–0795/08/0199–299 q 2008 Society for Endocrinology Printed in GreatMAPK3/1 protein phosphorylation. Brief exposure of
INGAP-PP-treated islets to carbachol (Cch) significantly
increased P70S6K-Thr389 and MAPK3/1 phosphorylation and
these islets released more insulin when challenged with Cch
that was prevented by the M3 receptor antagonist 4-DAMP,
in a concentration-dependent manner. In conclusion, these
data indicate that short- and long-term exposure to INGAP-
PP significantly affects the expression and the phosphorylation
of proteins involved in islet PI3K and MAPK signaling
pathways. The observations of INGAPP-PP-stimulated
up-regulation of cholinergic M3 receptors and PLC-b2
proteins, enhanced P70S6K and MAPK3/1 phosphorylation
and Cch-induced insulin secretion suggest a participation of
the cholinergic pathway in INGAP-PP-mediated effects.
Journal of Endocrinology (2008) 199, 299–306Introduction
Islet cell differentiation is controlled by several transcription
factors including pancreatic duodenal homeobox-1 (PDX-1),
neurogenin3, Nkx-1 and many others (Jensen et al. 2000).
Hormonal, chemical, and neural signals are also essential for
b-cell mass adaptation during its intrauterine development
(Nielsen et al. 2001). During the fetal and neonatal periods
more new b-cells are formed by neogenesis (Bouwens et al.
1994). Neogenesis is also observed in adult rodents after
pancreatic injury such as streptozotocin injection (Fernandes
et al. 1997), partial pancreatectomy (Lee et al. 1989),
pancreatic duct ligation (Wang et al. 1995, Xu et al. 2008),
cellophane wrapping of the pancreas head (Rosenberg &
Vinik 1993), and in sucrose-induced insulin resistance (Del
Zotto et al. 1999, 2000, Gagliardino et al. 2003).
Islet neogenesis associated protein (INGAP) was identified
as the active part of a pancreatic protein complex isolated fromnormal hamsters, whose pancreas heads had been wrapped in
cellophane (Pittenger et al. 1992). The Ingap gene is expressed
both in normal hamster islets and exocrine cells (Gagliardino
et al. 2003) and it has been shown that a pentadecapeptide
having the 104–118 amino acid sequence of INGAP (INGAP-
PP) reproduces the effect of the intact molecule upon
thymidine incorporation into ductal cells and a ductal cell
line (Rafaeloff et al. 1997). We have reported that offspring
from normal hamsters fed a sucrose rich diet during pregnancy
have an increase in b-cell mass, an increased number of PDX-1
and INGAP-positive cells together with the appearance of a
small population of cells that co-express PDX-1/INGAP.
Since these cells have a high replication rate and do not stain
with insulin-, glucagon-, somatostatin-, or PP-antibodies, we
postulated that they would be early precursors of islet cells
(Gagliardino et al. 2003). Otherwise, it was reported that the
administration of the pentadecapeptide to either normal adult
mice and dogs or streptozotocin-induced diabetic miceDOI: 10.1677/JOE-08-0309
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(Rosenberg et al. 2004, Pittenger et al. 2007). In addition,
neonatal and adult normal rat islets cultured with INGAP-PP
showed both increased b-cell size and insulin secretion in
response to glucose (Borelli et al. 2005).
Since islet transplantation for therapy of type 1 diabetes is
hampered by the shortage of islet donors, the search for
alternative sources of b-cells has been intensified. In this
sense, endogenous b-cell mass expansion and, consequently,
the reversal of hyperglycemic states in animal models are
being actively investigated (Rosenberg et al. 2004, Lipsett et al.
2006). Among the protocols used for this purpose INGAP-
PP seems to be a suitable tool, but its mechanism of action is
not yet completely elucidated.
It has been reported that the pancreas retains the ability to
regenerate a functioning b-cell mass in the postnatal period
(Rosenberg 1995). This process of progenitor cell transfor-
mation that leads to islet neogenesis could be mediated, at
least in part, by local pancreatic growth factors. It has been
shown that INGAP-PP treatment of duct-like structures,
obtained from quiescent adult human islets, induced their
differentiation to islet-like structures with the four endocrine
cell types showing a normal glucose-induced insulin secretion
(Jamal et al. 2005). In clinical trials (Ratner et al. 2005a,b)
INGAP-PP therapy has been found to reduce daily average
blood glucose levels at 90 days in patients with type 2 diabetes
and induce a significant increase in C-peptide secretion in
patients with type 1 diabetes. Recently, we have further
observed that in addition to its effects to stimulate insulin
secretion, INGAP-PP treatment augmented the expression of
several genes involved in the control of islet growth and
development (Barbosa et al. 2006).
Different pathways are involved in the mechanism by
which glucose and peptides such as incretin hormones
stimulate b-cell growth and differentiation (Hui et al. 2003,
Kluz & Adamiec 2006). Incretin effects are apparently
mediated through stimulation of cyclic AMP/PKA, p42
MAPK and PI3K pathways associated with the transcriptional
activity of cyclin D1 (Friedrichsen et al. 2006), while glucose
promotes human b-cell mitogenesis by stimulating p44/p42
MAPKs and FRAP1/P70S6K phosphorylation (Guillen et al.
2006). These and other reports suggest that MAPK and PI3K
cascades may be the major pathways involved in the
stimulatory effect of different factors upon islet mass
regulation.
In the present study, we show that the enhancing effect of
short- and long-term exposure of neonatal rat islets to
INGAP-PP upon dynamic insulin secretion is accompanied
by an increase of both PI3K and MAPK protein phosphoryl-
ation, and of the expression of components of the cholinergic
pathway, such as the M3 receptor subtype and phospholipase
C (PLC)-b2. Furthermore, Cch significantly increased the
short-term induced phosphorylation of proteins from the
PI3K and MAPK cascades as well as insulin secretion,
suggesting a possible participation of the cholinergic pathway
in this process.Journal of Endocrinology (2008) 199, 299–306Material and Methods
Reagents
Reagents used for RT-PCR were from Invitrogen and Sigma.
The equipment for SDS-PAGE and immunoblotting was
from Bio-Rad. All the chemicals used in the experiments for
immunoblotting and buffers were from Sigma. Anti-muscar-
inic receptor M3 (rabbit polyclonal sc-9108), anti-PLC-b2
(rabbit polyclonal, sc-9018), anti-Akt1 (rabbit polyclonal,
sc-8312), anti P70S6K (mouse monoclonal sc-8418) anti-pho-
spho Akt1-Ser473 (rabbit polyclonal, sc-7985), anti-MAPK3
(rabbit polyclonal, sc-94), anti-MAPK 2 (rabbit polyclonal,
sc-154), and anti-phospho MAPK3/1-Thr202/Tyr204 (mouse
monoclonal sc-7383) antibodies were from Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA; and anti-phospho
P70S6K-Thr389 (mouse polyclonal, #9206S) was from Cell
Signaling Technology Inc., Boston, MA, USA.Islets isolation and culture
Islets of neonatal Wistar rats were obtained by collagenase
digestion of pancreas in Hanks’ balanced salt solution and
cultured in RPMI-1640 medium supplemented with 5% fetal
bovine serum, 10 mM glucose, 100 IU penicillin/ml, 100 mg
streptomycin/ml at 37 8C in a 5% CO2/air atmosphere. In
short-term experiments groups of 300 islets were cultured for
two days to minimize contamination by exocrine tissue. In
other studies the islets were cultured for 4 days in the absence
(controls) or the presence of 10 mg/ml of INGAP-PP, as
reported (Barbosa et al. 2006), renewing the medium every
day. All animal experiments were approved by the Committee
for Ethics in Animal Experimentation of the State University
of Campinas (CEEA/IB/UNICAMP).Insulin secretion
To study dynamic secretion groups of 60 neonatal rat islets,
previously cultured for two days in control conditions, were
placed in individual chambers and perifused with krebs ringer
buffer (KRB), previously gassed with a mixture of CO2/O2
(5/95%), pH 7.4) and maintained at 37 8C in a temperature-
controlled environment (Persaud et al. 1989). The islets were
first pre-perifused for 1 h at 2 mM glucose, followed by a
70 min perifusion with the medium containing 2 or 20 mM
glucose in the absence or presence of INGAP-PP (10 mg/ml).
Medium samples were collected at 2 min intervals. To study
static insulin secretion groups of five neonatal rat islets,
previously cultured for 4 days in the absence or presence of
INGAP-PP, were then pre-incubated in 0.6 ml of KRB
containing 1.5% (w/v) BSA and 5.6 mM glucose at 37 8C for
45 min. After this period, the islets were further incubated in
1 ml KRB supplemented with 8.3 mM glucose for 1 h in the
absence or presence of 200 mM Cch and 1-100 nM 4-DAMP
(Boschero et al. 1995). Aliquots from the static incubation and
perifusion experiments were stored frozen for insulinwww.endocrinology-journals.org
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alcohol–acid solution for insulin extraction and subsequent
insulin immunoassay (data not shown). All results were
normalized against insulin content from each well or chamber.RT-PCR
Semi-quantitative RT-PCR was performed using specific
primers to analyze gene expression of Akt1 (NM 033230),
FRAP1 (NM 019906), and MAPK1 (M 64300). Reverse
transcription was carried out with 3 mg total RNA using
Moloney murine leukemia virus reverse transcriptase (Super-
script II) and random hexamers, according to the manufacturer’s
instructions (Invitrogen). RT-PCR assays were done in
quadruplicate using recombinant Taq DNA polymerase
(Invitrogen) and 10 pM of each primer in a master mix of
50 ml.The primer sets used in the RT-PCR analyses are shown in
Table 1. The number of cycles for each gene was defined after
titration using 20 to 42 cycles and was within the logarithmic
phase of amplification. PCR products were separated on 1.5%
EtBr-agarose gels and the band intensities were determined by
digital scanning (GelDoc 2000, Bio-Rad) followed by quantifi-
cation using Scion Image analysis software (Scion Corp.,
Frederick, MD, USA). The results were expressed as a ratio of
target to ribosomal protein (RP)S-29 signals.TheRNAsused for
RT-PCR analysis were obtained from three sets of experiments.Tissue extracts and immunoblotting
Cultured islets were homogenized in 100 ml solubilizing buffer
(10% Triton-X 100, 100 mM Tris, pH 7.4, 10 mM sodium
pyrophosphate, 100 mM sodium fluoride, 10 mM EDTA,
10 mM sodium vanadate, and 2 mM phenylmethylsulphonyl
fluoride) for 30 s using a Polytron PT 1200 C homogenizer
(Brinkmann Instruments, Westbury, NY, USA) and boiled for
5 min. The extracts were then centrifuged at 12 600 g at 4 8C
for 20 min to remove insoluble material. The protein
concentration in the supernatantswas assayed using the Bradford
dye method and the BioRad reagent. The proteins obtained
were treated with Laemmli sample buffer containing dithio-
threitol and boiled for 5 min. Seventy micrograms of protein
from each samplewere then applied to a 10% polyacrylamide gel
and separated by SDS-PAGE in a BioRad miniature slab gel
apparatus. The protein fractions were thereafter electrotrans-
fered from the gel to nitrocellulose at 120 V for 90 min in a
BioRad miniature transfer apparatus. Before incubation with
the primary antibody, the nitrocellulose filters were treated withTable 1 RT-PCR primer sets with predicted product sizes
Genebank Forward primer Reverse pri
Gene
Akt1 NM 033230 CCTCAAGTACTCATTCCAGAC CTCATACA
Frap1 NM 019906 AAGGAGATGCAGAAGCCTCAGT TGTCCCAA
Mapk1 M 64300 GACCCAAGTGATGAGCCCATTG AAGCCACT
www.endocrinology-journals.orga blocking buffer (5% non-fat dried milk, 10 mM Trizma,
150 mM NaCl, and 0.02% Tween 20) for 2 h at 22 8C. The
membranes were then incubated for 4 h at 22 8C with
antibodies against muscarinic receptor M3 (1:500), PLC-b2
(1:1,000), p-MAPK3/1 (1:500), MAPK3/1 (1:1,000), P70S6K
(1:500), p-P70S6K (1:1,000), Akt1 (1:500) or p-Akt1 (1:500)
diluted in blocking buffer with 3% non-fat dried milk, and then
washed for 30 min in blocking buffer without milk. The blots
were subsequently incubated with peroxidase-conjugated
second antibody for 1 h. Specific protein bands were revealed
using commercial enhanced chemiluminescence reagents with
exposure to photographic film. The images were obtained by
digital scanning on GelDoc 2000, BioRad, followed by
quantificationusing Scion Image analysis software (ScionCorp).Statistical analysis
Results are shown as meansGS.E.M.; appropriate statistical
comparisons between INGAP-PP-treated islets and the
respective control groups were carried out using Student’s
unpaired t-test. Differences were considered significant when
P values were!0.05.Results
Short-term effect of INGAP-PP on islet Akt1 and MAPK3/1
phosphorylation and on insulin secretion
Akt1 phosphorylation increased twofold when neonatal rat
islets were exposed to 10 mg/ml INGAP-PP for either 90 s or
5 min (P!0.05), returning to control values after 15 min
(Fig. 1A). INGAP-PP also significantly increased MAPK3/
1-Thr202/Tyr204 phosphorylation that lasted for 30 min after the
peptide exposure, being 4.1-, 4.0-, 2.2-, and 2.8-fold higher
than control at 90 s, 5, 15, and 30 min respectively (P!0.05;
Fig. 1B). To verify whether insulin secretion was also affected
by exposure to INGAP-PP, islets were perifused with a buffer
medium containing 2 mM or 20 mM glucose in the absence
or presence of the peptide (10 mg/ml). At 2 mM glucose
(Fig. 2A) addition of INGAP-PP provoked a rapid and
sustained twofold increase in insulin secretion (min 11–30).
This effect was rapidly reversed by the removal of INGAP-PP
from the perifusion medium. To determine whether the islets
maintained their viability after INGAP-PP exposure, the
glucose concentration was increased to 20 mM (min 51–70)
and this resulted in a significant increase in the insulinmer TM (8C) Cycle number Product (bp)
CATCTTGCCACAC 58 26 619
AGCCCATTAGGTCT 58 29 249
ACGACCAGACTGCC 56 24 253
Journal of Endocrinology (2008) 199, 299–306
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Figure 1 Acute effects of INGAP-PP on Akt1 and MAPK3/1
phosphorylation in neonatal rat islets. Two days cultured control
islets were acutely exposed to 10 mg/ml of INGAP-PP for 90 s, 5, 15,
and 30 min and islet extracts were immunoblotted with anti-
phospho-Akt1 (A) and anti-phospho- MAPK3/1 (B) antibodies.
The bars represent the relative phosphorylation of the proteins
(normalized against the total protein) measured by optical
densitometry, and are the meansGS.E.M. of four experiments.
The same letters indicate the pair comparisons that are significantly
different (P!0.05).
H C BARBOSA and others . INGAP signaling in pancreatic rat islets302secretion. Figure 2B shows that increasing the glucose
concentration from 2 to 20 mM (min 11–30) stimulated
insulin secretion from perifused islets and that this secretory
response was further potentiated by INGAP-PP (min 31–50)
to levels approximately twofold higher than those obtained
with 20 mM glucose alone. However, the potentiation of
insulin secretion induced by INGAP-PP was transient and
insulin levels returned to values comparable with those
elicited by 20 mM glucose before INGAP-PP withdrawal.Figure 2 Kinetics of INGAP-PP-evoked stimulation of insulin
secretion. Two-day cultured control islets were continuously
perifused with KRB buffer at 37 8C. After a pre-incubation period of
1 h (2 mM glucose) the effluent was collected each 2 min for
70 min. INGAP-PP (10 mg/ml) was applied as indicated either in the
presence of 2 mM (A) or 20 mM glucose (B). Results are expressed
as % of mean values calculated for min 0–10 (2 mM glucose), and
normalized against total insulin content. Insulin secretion rates are
meansGS.E.M. from three different experiments, * P!0.05
compared with basal insulin secretion (2 mM glucose) and
** P!0.05 compared with 20 mM glucose.Long-term effect of INGAP-PP on islet Akt1, Frap1 and
Mapk1 gene expression, and Akt1 and Mapk3/1
phosphorylation
RNA obtained from islets that had been maintained in the
presence of INGAP-PP for 4 days was submitted to semi-
quantitative RT-PCR analysis and normalized against the RPS-
29 housekeeping gene. INGAP-PP induced in cultured islets a
significant increase in Akt1, Frap1 and Mapk1 gene expression
attaining 1.9-, 1.6-, and 1.5-fold higher values than control islets
(P!0.05; Fig. 3A). Islets that had been exposed to INGAP-PP
for 4 days also showed increased basal phosphorylation of Akt1
and MAPK3/1, with levels 1.8- and 1.5- fold respectively
higher than control islets (P!0.05; Fig. 3B).Long-term effect of INGAP-PP on the expression of muscarinic
M3 subtype receptor, PLC-b2 proteins, and on Cch-induced
acute phosphorylation of P70S6K and MAPK3/1
Due to the role of cholinergic pathway in the mechanism of
insulin secretion, induced either by acetylcholine or glucose,Journal of Endocrinology (2008) 199, 299–306and considering that gene expression of the M3 receptor
subtype was up-regulated by INGAP-PP after 4 days culture,
in the next series of experiments we analyzed M3 receptor
and PLC-b2 expression as well as the effect of Cch on protein
phosphorylation of the PI3K and MAPK pathways. Protein
levels of the muscarinic M3 receptor subtype and PLC-b2
were significantly higher in islets cultured for 4 days in the
presence of INGAP-PP than in controls (Fig. 4A and B).
Basal P70S6K phosphorylation was similar in INGAP-
PP-treated and control islets and exposure of these islets to
200 mM Cch for short periods of time (90 s, 5 and 15 min)www.endocrinology-journals.org
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Figure 3 Effects of culture with 10 mg/ml of INGAP-PP for 4 days on
mRNA levels of Akt1, Frap1, and Mapk1 (A), and on Akt1 and
Mapk3/1 (B) phosphorylation. A: RT-PCRs annealing temperatures
and cycle numbers used were as follows: 58 8C and 26 cycles for
Akt1; 58 8C and 29 cycles for Frap1; 56 8C and 24 cycles for
MAPK1. Results were normalized to the RPS-29 housekeeping
gene. B: islet extracts were immunoblotted with anti-phospho-Akt1
and anti-phospho-MAPK3/1 antibodies (normalized against the
total protein). Plotted columns are meansGS.E.M. of 12 experiments
for mRNA and four experiments for protein phosphorylation.
* P!0.05 versus control.
Figure 4 Effect of culture with 10 mg/ml of INGAP-PP for 4 days on
muscarinic receptorM3 subtype (A) and PLC-b2 (B) expression. Islet
extracts were immunoblotted with anti-muscarinic receptor and
anti-PLC-b2 antibodies. The bars represent the relative protein
expression as determined by optical densitometry, and are the
meansGS.E.M. of three experiments, normalized to b-actin protein
expression, * P!0.05 versus controls. Open and closed bars
represent islets from control and INGAP-PP-cultured rat islets,
respectively.
INGAP signaling in pancreatic rat islets . H C BARBOSA and others 303significantly increased phosphorylation in both groups.
However, Cch-stimulated P70 S6K phosphorylation was
significantly higher in INGAP-PP-treated islets than in
control islets (4.4-, 6.9- and 4.3-fold for INGAP-PP-treated
versus 2.5-, 1.5- and 2.0-fold for control islets at 90 s, 5, and
15 min respectively; P!0.05; Fig. 5A). MAPK3/1 phos-
phorylation was also similar in INGAP-PP-treated and
control islets and exposure to Cch for 90 s induced a similar
and significant increase in MAPK3/1 phosphorylation in
treated and control islets (3.2-fold) compared with appro-
priate controls (no Cch). While the Cch-induced MAPK3/1
phosphorylation increment returned to basal values after
5 min in control islets, it remained significantly higher in
INGAP-PP-cultured islets at 5 and 15 min (3.7 and 2.3 versus
control respectively; P!0.05; Fig. 5B).Effects of Cch on insulin release from INGAP-PP-cultured and
control islets
Insulin secretion at 8.3 mM glucose was higher in INGAP-
PP-cultured islets compared with control islets (P!0.05;
Fig. 6). When 200 mM Cch was added to the incubation
medium insulin secretion increased 5.7 times in the INGAP-
PP-cultured and 1.5 times in the control islets. Thiswww.endocrinology-journals.orgstimulatory effect of Cch was dose-dependently inhibited by
increasing concentrations of 4-diphenylacetoxy-N-methylpi-
peridine (DAMP), a selective antagonist of M3 receptors,
with complete inhibition observed at 10 nM for INGAP-
PP-cultured islets and at 1 nM for control islets.Discussion
It is generally accepted INGAP-PP increases b-cell mass and
insulin secretion in response to different stimuli (Borelli et al.
2005, Jamal et al. 2005, Barbosa et al. 2006, Lipsett et al. 2006).
We have also recently demonstrated that INGAP-PP
simultaneously enhanced insulin secretion and up-regulated
several genes related to protein synthesis and islet maturation
in neonatal rat islets (Barbosa et al. 2006). However, the
mechanism by which INGAP-PP produced these effects is
not yet fully elucidated. It has been reported that culturing
isolated adult human islets for 10 days in a simple medium
resulted in the disappearance of b-cells from the islet core and
when these ghost islets were cultured with INGAP-PP for
4 days the islets were rebuilt and the newly formed b-cells
released insulin in response to glucose at levels comparable
with freshly isolated adult islets. Using a variety of blockers it
was concluded that the effects of INGAP-PP were due to
activation of the PI3K pathway (Jamal et al. 2005). It is still a
matter of debate whether most of the new b-cells in adult
animals are formed by the replication of resident b-cells (Dor
et al. 2004) or if they are derived from ductal or other
pancreatic precursor cells (Noguchi et al. 2006, Yatoh et al.
2007, Xu et al. 2008). Jamal et al. (2005) have suggested that
the enhancing effect of INGAP-PP upon b-cell mass was
obtained by a direct effect upon the remaining external islet
cells that presumably conserves characteristics of ductal cells.Journal of Endocrinology (2008) 199, 299–306
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Journal of Endocrinology (2008) 199, 299–306Neonatal islets exposed to INGAP-PP for short periods of
time (90 s, 5, 15, and 30 min) showed a significant increase in
Akt1/2/3- and MAPK3/1 phosphorylation (Fig. 1) support-
ing the early proposal that both PI3K and MAPK pathways
may act as intracellular mediators of the beneficial effect of
INGAP-PP upon b-cell mass and viability (Jamal et al. 2005).
These short-term effects of INGAP-PP upon the phosphoryl-
ation of proteins that belong to the PI3K and MAPK cascades
were also observed when neonatal islets were cultured with
INGAP-PP for 4 days (Akt1 and MAPK3/1) together with an
increase of Akt1, Frap1, and Mapk1 gene expression.
Long-term exposure of neonatal islets to INGAP-PP also
increased expression of members of the cholinergic pathway,
namely the M3 receptor subtype and PLC-b2. Furthermore,
4-DAMP (a selective M3 inhibitor) significantly inhibited Cch-
stimulated insulin release. These results strongly suggest that the
enhanced insulin secretion induced by cholinergic stimulus in
INGAP-PP-cultured isletswas due, at least in part, to an increase
in the expression of the M3 muscarinic receptor subtype. It has
been reported that in MIN6 b-cells, PLC activation by Ca2C is
an essential step for the stimulatory effect of Cch upon insulin
secretion (Thore et al. 2005); such a mechanism includes an
intracellular Ca2Cmobilization phase and a sustained activation
phase dependent on Ca2C entry through non voltage-
dependent channels present in the plasma membrane. Since
the expression of PLCb2 was increased in INGAP-PP-cultured
islets it is conceivable that higher levels of intracellular [Ca2C] in
these islets (Silva et al. 2008) could account for the increased
secretion of insulin via a higher PLC-b2 activity. The increased
expression of the two KCKATP dependent channels component
genes (Barbosa et al. 2006) and the increase in intracellular
[Ca2C], would also contribute to the enhanced release of insulin
observed in INGAP-PP cultured islets. Furthermore, Cch
significantly augmented P70S6K and MAPK3/1 protein
phosphorylation in these islets. Altogether, these results suggest
participation of the cholinergic pathway in the mechanism by
which INGAP-PP increases insulin secretion.
Activation of PI3K and MAPK pathway proteins occurs
following both short- and long-term exposure to INGAP-PP. It
has been shown that activation of those pathways is a common
mechanism shared by several hormones, growth factors and
substances that affect tissue growth and differentiation in many
cell types. For example, MAPK3/1 phosphorylation is
potentiated by glucose, incretins, IGF-1 and glyburide in
INS-1 cells (Briaud et al. 2003). Prolactin also activates PI3K andFigure 5 Acute effects of 200 mM Cch on P70S6K and MAPK3/1
phosphorylation in islets for 4 days in the absence or presence of
10 mg/ml INGAP-PP. After culture, control and INGAP-PP islets
were exposed to Cch for 90 s, 5, and 15 min. Islet extracts were
immunoblotted with anti-phospho-P70S6K (A) and anti-phospho-
MAPK3/1 (B) antibodies. The bars represent the relative phos-
phorylation of the proteins (normalized against the total protein)
determined by optical densitometry, and are the meansGS.E.M. of
four experiments. The same letters indicate the pairs comparisons
that are significantly different (P!0.05).
www.endocrinology-journals.org
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Figure 6 Effect of 4-DAMP on 200 mM Cch-induced insulin
secretion in control and INGAP-PP-cultured (10 mg/ml) neonatal
rat islets for 4 days. After culture, groups of 5 islets were incubated
in KRB buffer containing 8.3 mM glucose in the absence or
presence of 200 mM Cch and increasing concentrations of the M3
receptor antagonist 4-DAMP (1 nM, 10 nM and 100 nM). The bars
represent cumulative 1 h insulin secretion and are meansGS.E.M. of
14–20 groups of islets from three different experiments. The same
letters indicate the pairs comparisons that are significantly different
(P!0.05) between groups. Light and dark bars represent islets from
control and INGAP-PP-cultured islets respectively.
INGAP signaling in pancreatic rat islets . H C BARBOSA and others 305MAPK cascades in cultured neonatal rat islets and in islets from
pregnant rats, underlining the importance of these pathways in
growth and development of islets in both periods of life (Amaral
et al. 2003, 2004). In addition, MAPK6, a memberof the MAPK
cascade, is involved in the process of insulin granule exocytosis
possibly through the complex MAPK6/MAP2, and via
conventional PKCs activation (Anhe et al. 2006, Cunha et al.
2007). Moreover, it has been postulated that phosphorylation of
synapsin I, a protein involved in glucose-induced insulin
secretion, is dependent on MAPK3/1 activation (Longuet
et al. 2005). Thus, our findings concerning INGAP-PP-in-
duced phosphorylation of proteins of the MAPK and PI3K
pathways are in good agreement with the literature mentioned
above.
There is also evidence of participation of the cholinergic
pathway in cell growth in other tissues. Thus, a) Cch increases
[Ca2C]i, MAPK1 phosphorylation, protein synthesis, and cell
proliferation in a human breast cancer cell line (Jimenez &
Montiel 2005); b) M3 muscarinic cholinergic receptors
activate p70S6K1 via PI3K signaling pathway in astrocytoma
cells (Tang et al. 2003, Batty et al. 2004); c) a novel pathway of
acetylcholine-stimulated activation of eNOS, involving the
JAK2/IRS-1/PI3K/ Akt1 pathway, has recently been
reported in aorta of obese rats that are simultaneously resistant
to insulin and Cch (Zecchin et al. 2007); and d) islet M1 and
M3 muscarinic receptor expression is increased during islet
cell regeneration (Renuka et al. 2005). The increased
expression of such receptors is associated with an increase in
insulin secretion that, in turn, might modulate b-cell growth
and differentiation via IRS2 activation (Velloso et al. 1995).www.endocrinology-journals.orgIn conclusion, our data show that both short- and long-
term exposure of neonatal normal rat islets to INGAP-PP
activates islet PI3K and MAPK pathways and increases the
expression of muscarinic M3 receptors and PLC-b2 proteins.
In INGAP-PP-cultured islets, a brief exposure to Cch
enhanced the phosphorylation of several components of
both signaling cascades leading to an increase in insulin
secretion. This latter phenomenon suggests that the effect of
INGAP-PP upon pancreatic islets is due, at least in part, to the
activation of the cholinergic pathway. In light of the beneficial
effects of INGAP-PP on b-cell function INGAP-PP
supplementation of human islets, maintained in culture
prior to transplantation therapy, could be a suitable strategy
to optimize their viability and secretory function.Declaration of interest
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